Search clinical trials for: Sofosbuvir Oral Product

Total 10970 results

Gilead Sciences

Completed

Efficacy and Safety of Sofosbuvir/Velpatasvir Fixed Dose Combination for 12 Weeks in Adults With Chronic Hepatitis C Virus (HCV) and Human Immunodeficiency Virus (HIV)-1 Coinfection (ASTRAL-5)

Hepatitis C Virus Infection

United States
Universidad de Murcia

Completed

Evaluation of the Beneficial Health Effects of an Additive-free Meat Product in Healthy Subjects (HIPOCARNE)

Inflammation | Oxidative Stress | Food Toxicity

Spain
Danone Research

Completed

Evaluation of Dose-effect of a New Fermented Food in Healthy Adults

Healthy

Germany
Assiut University

Unknown

Effect Of DAAs For Treatment Of HCV On Normal Kidney

Antiviral Drug Adverse Reaction
Roquette Canada, LTD.

Completed

Investigation of the Efficacy and Safety of Three Test Products and Comparator on Muscular Performance After the Initiation of a Resistance Training Program

Muscle Strength

Canada
Partners in Health

Unknown

Simplifying HCV Treatment in Rwanda for Elsewhere in the Developing World: Pangenotypic and Retreatment Study (SHARED3) (SHARED3)

Hepatitis C, Chronic

Rwanda
Center For Hepatitis C, Atlanta, GA

Active, not recruiting

Treatment of HCV-Infected Recent Injection Drug Users in U.S. Liver Clinics

Chronic Hepatitis C | People Who Inject Drugs

United States
Kirby Institute

Completed

Randomised Study of Interferon-free Treatment for Recently Acquired Hepatitis C in PWID and People With HIV Coinfection. (REACT)

Hepatitis C

Australia, United States, United Kingdom, New Zealand, Switzerland, Canada, Germany, Netherlands
Gilead Sciences

Completed

Efficacy and Safety of Ledipasvir/Sofosbuvir Fixed Dose Combination in the Treatment of Hepatitis C Virus (HCV) Infection in Pediatric Participants Undergoing Cancer Chemotherapy

Hepatitis C Virus Infection

Egypt
Tarek I. Hassanein, M.D., FACP, FAG, AGAF

Completed

Study to Evaluate the Safety and Efficacy of Daclatasvir/Sofosbuvir/Ribavirin for 16 Versus 24 Weeks for HCV Genotype 3 Cirrhotics

Hepatitis C | Cirrhosis

United States
Gilead Sciences

Completed

Efficacy and Safety of Sofosbuvir/Velpatasvir Fixed Dose Combination for 12 Weeks in Participants With Chronic HCV

Hepatitis C Virus Infection

Singapore, Vietnam, China, Thailand, Malaysia
Gilead Sciences

Completed

Efficacy and Safety of Sofosbuvir/Velpatasvir Fixed-Dose Combination (FDC) and Sofosbuvir/Velpatasvir FDC and Ribavirin in Participants With Chronic Genotype 3 HCV Infection and Cirrhosis

Hepatitis C Virus Infection

Spain
Gilead Sciences

Completed

Ledipasvir/Sofosbuvir Fixed-Dose Combination Plus Ribavirin in Participants With Chronic HCV With Advanced Liver Disease or Post-Liver Transplant

Chronic HCV Infection

Belgium, Austria, New Zealand, United Kingdom, Germany, Spain, Netherlands, France, Switzerland, Canada, Australia, Italy
Gilead Sciences

Terminated

Efficacy and Safety of Ledipasvir/Sofosbuvir, With or Without Ribavirin, in HCV Infected Participants Who Have Failed Prior Treatment With Sofosbuvir-based Therapies

Hepatitis C Virus Infection

United States, Canada, Puerto Rico
AB Biotics, SA

Completed

Impact of a Probiotic-based Formula on Digestive Symptoms and Mood in Ultra Marathon Runners (AB-ULTRA)

Signs and Symptoms

Spain
Church & Dwight Company, Inc.
Essential Access Health

Completed

Synthetic Male Condom Slippage-Breakage Study

Sexually Transmitted Diseases | Contraceptive

United States
Gilead Sciences

Completed

Sofosbuvir/Velpatasvir Fixed-Dose Combination in Adults With Chronic HCV Infection and Child-Pugh Class B Cirrhosis (ASTRAL-4)

Hepatitis C Virus Infection

United States, Puerto Rico
Abbott Nutrition

Completed

Comparison of Nutritional Products for People With Type 2 Diabetes

Diabetes Mellitus, Type 2

Spain
Johns Hopkins Bloomberg School of Public Health
Bill and Melinda Gates Foundation; International Centre for Diarrhoeal Disease...

Completed

Protein Plus: Improving Infant Growth Through Diet and Enteric Health (JiVitA-6)

Stunting | Campylobacter Infections | Malnutrition; Protein | Enteric Pathogens

Bangladesh
Medstar Health Research Institute

Active, not recruiting

Myomectomy vs Uterine Artery Embolization vs GnRh Antagonist for AUB-L (Magical)

Fibroid Uterus | Heavy Menstrual Bleeding

United States
Gilead Sciences

Completed

Efficacy and Safety of Ledipasvir/Sofosbuvir Fixed-Dose Combination for 12 Weeks in Subjects With Chronic Genotype 1 or 4 HCV and HIV-1 Co-infection

HIV | Hepatitis C Virus

United States, New Zealand, Canada, Puerto Rico
Gilead Sciences

Completed

Sofosbuvir/Velpatasvir Fixed Dose Combination for 12 Weeks in Adults With Chronic HCV Infection (ASTRAL-1)

Hepatitis C Virus Infection

United States, France, Canada, Germany, Puerto Rico, United Kingdom, Belgium, Italy, China
Pharmtechnology LLC
Altasciences Company, Inc.

Completed

The Bioequivalence Study of Two Different Formulations of Candesartan Cilexetil After a Single Oral Dose Administration Under Fasting Conditions

Bioequivalence

Canada
Biogen

Completed

Study in Healthy Volunteers to Establish the Bioequivalence of Two Different Manufacturers.

Healthy Volunteers

United States
University of Michigan
DMG Dental Material Gesellschaft mbH

Completed

Radiographic Progression of Infiltrated Caries Lesions In-vivo (ICON)

Dental Caries

United States
Sanofi

Completed

Study of the Tolerability of Different SAR153191 Drug Products, That Differ With Respect to Manufacturing Processes and Formulation, at Different Concentrations and Doses in Healthy Male Subjects

Rheumatoid Arthritis
Fooyin University

Recruiting

The Clinical Evaluation of Probiotics Product in Patients With Various Functional Bowel Disorders and Helicobacter Pylori Infection

Helicobacter Pylori Infection | Bowel Dysfunction

Taiwan
Abbott Nutrition

Terminated

Use of a Medical Food in Adults Undergoing Surgery

Compliance, Patient

United States
ForSight Vision5, Inc.

Completed

A Study of the VISION5 Product in Patients With Glaucoma or Ocular Hypertension

Primary Open Angle Glaucoma | Ocular Hypertension

Latvia
Ohio State University
Emory University; Nationwide Children's Hospital

Terminated

Postpartum Family Planning

Delay in Time to Lactogenesis Stage II

United States
Laboratorios Andromaco S.A.

Completed

Bioavailability of Desogestrel 0.075 mg Tablets With Regards to Reference Product

Bioequivalence

Chile
Gilead Sciences

Completed

Ledipasvir/Sofosbuvir Fixed-Dose Combination + Ribavirin in Subjects With Chronic HCV With Advanced Liver Disease or Post-Liver Transplant

Chronic HCV Infection

United States
Gilead Sciences

Completed

Efficacy And Safety Of Sofosbuvir/Velpatasvir Fixed Dose Combination With Ribavirin in Chronic HCV Infected Adults Who Participated in a Prior Gilead Sponsored HCV Treatment Study

Hepatitis C Virus Infection

United States, New Zealand, Puerto Rico, Australia
Gilead Sciences

Completed

Safety and Efficacy of Ledipasvir/Sofosbuvir Fixed Dose Combination, With or Without Ribavirin, in Egyptian Adults With Chronic Genotype 4 HCV Infection

Hepatitis C Virus Infection

Egypt
Gilead Sciences

Completed

Safety and Efficacy of Ledipasvir/Sofosbuvir (LDV/SOF) Fixed Dose Combination Tablet With Ribavirin for 12 Weeks in Treatment-naive Adults With Chronic HCV Genotype 3 Infection

Hepatitis C Virus Infection

Canada
Arrowhead Regional Medical Center

Unknown

Outcome of New Direct Acting Agents For Hepatitis C A Community Based Experience

Hepatitis C

United States
Radicle Science

Completed

Radicle Recharge: A Study of Health and Wellness Products on Energy Levels and Other Health Outcomes

Fatigue | Energy

United States
Peking University First Hospital

Recruiting

The Efficacy and Safety of 12-week SOF/VEL Regimen Combined With Prophylactic Use of TAF for Treatment-naïve Genotype 1-6 HCV/HBV Co-infection Adult Patients With or Without Compensated Cirrhosis in China (BDTAF)

Chronic Hepatitis B | Chronic Hepatitis C

China
Gilead Sciences

Completed

Safety and Efficacy of Ledipasvir/Sofosbuvir in Adults With Chronic HCV Infection

Hepatitis C Virus Infection

Estonia, Russian Federation
Pierre Fabre Dermo Cosmetique

Completed

Efficacy Study of Cosmetic Product RV3278AET0943 Versus Non-treated Group in Adults With Oily and Acne Prone Skin

Acne

France
Medicines Development for Global Health

Recruiting

Efficacy and Safety Study of Moxidectin in Adults With Scabies

Scabies

United States, Honduras
Grupo Español de Investigación en Neurooncología
Tilray; Medical Cannabis Bike Tour; Voices Against Brain Cancer

Recruiting

TN-TC11G (THC+CBD) Combination With Temozolomide and Radiotherapy in Patients With Newly-diagnosed Glioblastoma (GEINOCANN)

Glioblastoma

Spain
Gilead Sciences

Completed

Sofosbuvir/Velpatasvir Fixed-Dose Combination in HCV-Infected Adults Who Are Undergoing Liver Transplantation

Hepatitis C Virus Infection

New Zealand
Gilead Sciences

Completed

Safety and Efficacy of Ledipasvir/Sofosbuvir Fixed-Dose Combination ± Ribavirin for the Treatment of HCV (ION-3)

Chronic Hepatitis C Virus

United States
Colgate Palmolive

Completed

Clinical Study on Malodor

Oral Malodor

China
Société des Produits Nestlé (SPN)

Completed

Nutritional Intervention to Improve Sleep Quality and Improve Next-day Mood and Cognitive Benefits (Twinkle)

Sleep

Singapore
Danisco
BioFortis

Completed

Effect of an 8-week Bifidobacterium Lactis HN019 Supplementation on Functional Constipation (BifidoDigest)

Functional Constipation

France
Sociedad Española de Medicina Regenerativa y Terapia...

Recruiting

Clinical Study on the Efficacy of Natural Stem Cell Mobilizers on Parkinson Disease

Parkinson Disease

Spain
Wageningen University

Completed

Elucidating the Role of Human Small Intestine Microbiota in Explaining Differences in Postprandial Glucose Responses (GLYSIMI)

Obesity | Overweight | Metabolic Syndrome | Microbiota | Digestion | Small Intestine

Netherlands
Fougera Pharmaceuticals Inc.

Withdrawn

Study to Determine the Pharmacokinetics of Product 0405

Atopic Dermatitis

3

Subscribe